Hemant R. Jadhav

1.4k total citations
66 papers, 1.0k citations indexed

About

Hemant R. Jadhav is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Hemant R. Jadhav has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Pharmacology and 19 papers in Computational Theory and Mathematics. Recurrent topics in Hemant R. Jadhav's work include Computational Drug Discovery Methods (19 papers), Cholinesterase and Neurodegenerative Diseases (17 papers) and Alzheimer's disease research and treatments (8 papers). Hemant R. Jadhav is often cited by papers focused on Computational Drug Discovery Methods (19 papers), Cholinesterase and Neurodegenerative Diseases (17 papers) and Alzheimer's disease research and treatments (8 papers). Hemant R. Jadhav collaborates with scholars based in India, Australia and United Kingdom. Hemant R. Jadhav's co-authors include Mahaveer Singh, Priti Jain, Mahaveer Singh, Pankaj Wadhwa, Kamlesh K. Bhutani, Santosh Rudrawar, Suresh Purohit, Vikas Anand Saharan, Milton J. Kiefel and Andrew K. Davey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Biochemistry and Biophysics and Molecular Pharmacology.

In The Last Decade

Hemant R. Jadhav

59 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hemant R. Jadhav India 17 422 184 143 128 119 66 1.0k
Jinming Wu China 14 600 1.4× 311 1.7× 102 0.7× 92 0.7× 59 0.5× 36 1.2k
Simona Bertoni Italy 25 739 1.8× 177 1.0× 316 2.2× 181 1.4× 90 0.8× 77 1.6k
Cheng Chang United States 14 275 0.7× 93 0.5× 58 0.4× 73 0.6× 137 1.2× 29 747
Simona Sestito Italy 23 643 1.5× 379 2.1× 237 1.7× 192 1.5× 109 0.9× 94 1.7k
Marek Bednarski Poland 19 341 0.8× 96 0.5× 210 1.5× 114 0.9× 54 0.5× 79 1.1k
Zongtao Lin United States 24 572 1.4× 92 0.5× 169 1.2× 99 0.8× 39 0.3× 62 1.7k
Gianluca Miglio Italy 25 850 2.0× 218 1.2× 111 0.8× 123 1.0× 41 0.3× 54 1.8k
Rupinder Kaur Sodhi India 19 368 0.9× 226 1.2× 45 0.3× 131 1.0× 39 0.3× 52 979
Xiaowen Jiang China 23 670 1.6× 207 1.1× 116 0.8× 228 1.8× 102 0.9× 85 1.5k
Clint D.J. Tavares United States 18 1.1k 2.5× 273 1.5× 132 0.9× 88 0.7× 28 0.2× 24 1.6k

Countries citing papers authored by Hemant R. Jadhav

Since Specialization
Citations

This map shows the geographic impact of Hemant R. Jadhav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemant R. Jadhav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemant R. Jadhav more than expected).

Fields of papers citing papers by Hemant R. Jadhav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemant R. Jadhav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemant R. Jadhav. The network helps show where Hemant R. Jadhav may publish in the future.

Co-authorship network of co-authors of Hemant R. Jadhav

This figure shows the co-authorship network connecting the top 25 collaborators of Hemant R. Jadhav. A scholar is included among the top collaborators of Hemant R. Jadhav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemant R. Jadhav. Hemant R. Jadhav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jadhav, Hemant R., et al.. (2025). Novel therapeutic targets for cardiorenal syndrome. Drug Discovery Today. 30(1). 104285–104285. 1 indexed citations
2.
Gaikwad, Anil Bhanudas, et al.. (2024). A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease. European Journal of Medicinal Chemistry. 280. 116932–116932.
3.
Sharma, Amit, Santosh Rudrawar, Sandip B. Bharate, & Hemant R. Jadhav. (2024). Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective. RSC Medicinal Chemistry. 16(2). 652–693. 6 indexed citations
4.
Jadhav, Hemant R., et al.. (2024). Design, synthesis and evaluation of new methyl piperazine derivatives as anticancer agents. SHILAP Revista de lepidopterología. 10(1). 3 indexed citations
5.
6.
Jadhav, Hemant R., et al.. (2024). Bioactivity predictions and virtual screening using machine learning predictive model. Journal of Biomolecular Structure and Dynamics. 43(8). 3909–3928. 1 indexed citations
7.
Jadhav, Hemant R., et al.. (2024). A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation. Archives of Biochemistry and Biophysics. 756. 110019–110019. 5 indexed citations
8.
9.
10.
11.
Jain, Priti, et al.. (2023). Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer. Bioorganic Chemistry. 140. 106833–106833. 12 indexed citations
12.
Jadhav, Hemant R., et al.. (2023). FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approach. Journal of Biomolecular Structure and Dynamics. 42(24). 13497–13514. 5 indexed citations
13.
Nuthakki, Vijay K., et al.. (2023). Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors. Bioorganic Chemistry. 139. 106719–106719. 8 indexed citations
14.
Jain, Priti, et al.. (2022). A perspective on oligonucleotide therapy: Approaches to patient customization. Frontiers in Pharmacology. 13. 1006304–1006304. 73 indexed citations
15.
Singh, Mahaveer & Hemant R. Jadhav. (2017). Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors. Drug Discovery Today. 23(3). 745–753. 105 indexed citations
16.
Jadhav, Hemant R., et al.. (2016). EXPLORING VISCERAL ADIPOSITY INDEX AS A PREDICTOR OF VISCERAL ADIPOSITY DYSFUNCTION AND EVALUATING ITS PERFORMANCE IN PREDICTING HEPATIC INSULIN RESISTANCE IN INDIAN TYPE 2 DIABETICS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(8). 297–301. 4 indexed citations
17.
Saharan, Vikas Anand, et al.. (2015). Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems. Drug Development and Industrial Pharmacy. 42(8). 1291–1299. 9 indexed citations
18.
Singh, Mahaveer & Hemant R. Jadhav. (2014). Melatonin: functions and ligands. Drug Discovery Today. 19(9). 1410–1418. 155 indexed citations
19.
Saharan, Vikas Anand, et al.. (2013). Formulation, evaluation and 3 2 full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres. Pharmaceutical Development and Technology. 19(7). 839–852. 21 indexed citations
20.
Jadhav, Hemant R., et al.. (2010). Synthesis and Antioxidant Potential of Novel 2-Isoxazole Substituted Chromenones Synthesized by Microwave Irradiation. Asian Journal of Research in Chemistry. 3(1). 106–109. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinming Wu Breakdown of academic impact, for papers by Simona Bertoni Breakdown of academic impact, for papers by Cheng Chang Breakdown of academic impact, for papers by Simona Sestito Breakdown of academic impact, for papers by Marek Bednarski Breakdown of academic impact, for papers by Zongtao Lin Breakdown of academic impact, for papers by Gianluca Miglio Breakdown of academic impact, for papers by Rupinder Kaur Sodhi Breakdown of academic impact, for papers by Xiaowen Jiang Breakdown of academic impact, for papers by Clint D.J. Tavares
Rankless by CCL
2026